Potential of laser-driven VHEEs toward FLASH radiotherapy: Monte Carlo dosimetric study of single-field pencil beam scanning of a brain tumor
Leonida A. Gizzi, Damiano Del Sarto, Federico Avella, Gabriele Bandini, Simona Piccinini, Daniele Panetta, Davide Terzani, Luca Labate · 2026
Read Potential of laser-driven VHEEs toward FLASH radiotherapy: Monte Carlo dosimetric study of single-field pencil beam scanning of a brain tumor by Leonida A. Gizzi, Damiano Del Sarto, Federico Avella, Gabriele Bandini, Simona Piccinini, Daniele Panetta, Davide Terzani, Luca Labate (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2604-24417.txt.
Introduction
Gizzi and seven colleagues study laser-driven very high energy electrons for FLASH radiotherapy. Laser wakefield acceleration offers a compact source of electrons at ultra-high dose rates for the FLASH effect. Pencil beams show wide energy spread and small transverse size, unlike other beams. Start-to-end Monte Carlo simulations of a beam on a brain tumor achieve tumor coverage by scanning. Dose patterns from overlapping beamlets are examined. Dose histograms show quality, and FLASH adds healthy tissue sparing. The authors outline the path toward FLASH dose rates.
Catalog record
| CREATOR | Leonida A. Gizzi, Damiano Del Sarto, Federico Avella, Gabriele Bandini, Simona Piccinini, Daniele Panetta, Davide Terzani, Luca Labate |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45099 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2604.24417
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Potential of laser-driven VHEEs toward FLASH radiotherapy: Monte Carlo dosimetric study of single-field pencil beam scanning of a brain tumor Leonida A. Gizzi, Damiano Del Sarto, Federico Avella, Gabriele Bandini, Simona Piccinini, Daniele Panetta, Davide Terzani, Luca Labate Abstract Radiotherapy with Very High Energy Electron (VHEE) beams is being extensively investigated for the treatment of deep-seated tumours, even in view of novel protocols based on the so-called FLASH effect. Laser WakeField Acceleration (LWFA) provides a compact and affordable accelerator technology for VHEE electron beams, featuring ultra-high instantaneous dose rates and holding the promise to provide Ultra-High (average) Dose Rates (UHDRs) needed to activate the FLASH effect, with major efforts ongoing worldwide to fulfill this promise. Therapeutic doses are already at reach, using pencil beams produced via LWFA. These beams typically exhibit significant energy spread, and small transverse size. These features are rather different from those of other beams considered so far in radiotherapy studies. In view of a rapid clinical translation of LWFA-VHEE beams it is therefore of paramount importance to assess the role of these properties in the dose delivery to the patient. Here we present a study carried out via start-to-end (PIC and Monte Carlo) simulations, of the main dosimetric features of a realistic laser-driven VHEE pencil beam targeted on a brain tumor. The entire tumor coverage is achieved by a scanning procedure; the dose pattern resulting from tessellation, i.e. the overlapping of adjacent beamlets, and the role of energy spread are thoroughly discussed. Dose Volume Histograms are presented, and their quality is discussed. The impact of the FLASH effect is also considered, introducing a degree of healthy tissue sparing in the modelling. Finally, the foreseen technological path toward the achievement of FLASH dose rates with LWFA-VHEE beams is briefly outlined. Introduction and motivations Radiotherapy (RT) is an essential tool for cancer treatment, with more than 60% of new cancer patients in high income countries expected to undergo a RT treatment as part of their cancer management [ 73 ] . RT relies on the possibility of inducing lethal damage to tumor cells while keeping the adverse effects probability to the surrounding healthy tissue at an acceptable level. This is made possible by the usage of advanced dose conformation techniques and relies, ultimately, on the DNA repairing mechanisms operating more efficiently in healthy tissues rather than in tumors [ 12 ] . The so-called therapeutic window identifies the useful range of irradiation dose for which the probability of tumor control exceeds the probability of normal tissue damage, once repairing mechanisms take place. The quest for mechanisms able to increase this window is an active research field, whose findings would enable better treatments, in particular in the case of radio-resistant tumors and/or of tumors localized near sensitive organs. In this respect, the so-called FLASH effect [ 21 ] has sparked hope for a possible breakthrough in RT (for reviews on the matter see [ 52 , 69 , 70 ] ). It consists in a significant reduction of damage to healthy tissue at a given dose when ionizing radiation is delivered at ultra high dose rates (UHDR), of the order of several tens of \mathrm{Gy}/\mathrm{s} or more, orders of magnitude higher than the rates ( \sim\mathrm{Gy}/\mathrm{min} ) used in current RT protocols. Although the fundamental mechanisms underpinning the FLASH effect are still to be clarified [ 33 , 32 , 23 ] , a sparing of healthy tissue at ultra-high dose rates with preserved tumor control has now been confirmed in several studies (see [ 47 , 8 , 7 , 13 , 59 , 71 ] and Refs. therein). Crucial for the clinical translation of FLASH-based RT protocols are the properties of the radiation sources. Indeed, the dose rate needed for FLASH treatments requires high beam current, which is out of the range of operation of clinical accelerators used for the treatment of deep seated tumors, mainly because of the poor intrinsic conversion efficiency of the underlying Bremsstrahlung process leading to the generation of the deep penetrating photon beam starting from the multi MeV primary electron beam. Experiments carried out so far to investigate the FLASH effect, either in vitro , in vivo or as a compassionate treatment of superficial tumors in humans, have been carried out using conventional devices modified to provide ultra-high dose rates (see [ 61 , 19 ] and Refs. therein). In the vast majority of cases, electron beams with relatively low energy have been used, only suitable for irradiation at shallow depths [ 71 ] , such as in the case of skin [ 9 ] , eyes, salivary glands tumors [ 58 ] , or in IORT [ 57 ] . Electron beams capable of delivering FLASH dose rates, for instance, have been obtained by standard medical accelerators, by removing the electron-to-photon conversion element and tuning the beam forming and accelerating structures to sustain the needed high currents, and to provide, at the same time, beams with a suitable quality for radiobiology and medical experiments [ 40 , 55 , 22 ] ; electrons with a maximum energy up to \sim 20\,\mathrm{MeV} can be obtained in this way. Moreover, electron accelerators used for Intra Operative Radiation Therapy (IORT) are also available with FLASH dose-rates, with energy up to \sim 10\,\mathrm{MeV} and cm-wide beam size. These and other similar devices provide electron beams with UHDR with sufficient energy to irradiate superficial tumors and should be available soon for clinical applications. In contrast, the treatment of deep seated tumors at FLASH dose-rates would require much more penetrating beams. Availability of medical accelerators of charged particle beams with both high energy (high penetration depth) and current (UHDR) is hindered by size, complexity and cost issues, although efforts for technology development are ongoing. For instance, selected hadron therapy centers are currently capable of delivering FLASH dose-rate pencil beams and are starting to pave the way towards human clinical applications. In this context, the use of another type of particle beam, namely Very High Energy Electrons (VHEE), with energy in the range between 100 and 250\,\mathrm{MeV} , is considered extremely promising for clinical applications. The development of VHEE devices based on RF technology is currently actively pursued by different companies, usually in a joint effort with government laboratories [ 67 , 43 ] . An updated discussion of the ongoing research activity in this field can be found in [ 20 ] and in a very recent review [ 52 ] . As a matter of fact, originally, the use of high energy electrons to irradiate deep seated tumors was mostly investigated via theoretical/numerical studies. Up until the beginning of 2000s, the energy range considered was limited to \sim 50\,\mathrm{MeV} . More recently, in light of both technology advancements in conventional acceleration [ 16 , 72 , 51 ] and the emergence of laser-driven electron acceleration, dosimetric studies of VHEE beams started to be performed (see for instance [ 58 ] and Refs. therein). Monte Carlo simulations, in particular, have shown appealing features of VHEE, such as their reduced lateral spread in tissues with respect to both \lesssim 50\,\mathrm{MeV} e-beams and high energy protons (also in the case of FLASH modality [ 50 , 5 , 26